Key result
The ACE D/D genotype was found to be an independent predictive factor for retinal vein occlusion, significantly increasing the odds of the condition (OR 3.83, p=0.035).
Why the study?
Does the ACE D/D gene polymorphism increase the risk of retinal vein occlusion?
Case-Control (n=160)
Yes
Does the ACE D/D gene polymorphism increase the risk of retinal vein occlusion?
The ACE D/D gene polymorphism is an independent predictive factor for retinal vein occlusion, alongside diabetes mellitus and hypertension.
ACE D/D genotype may mark higher retinal vein occlusion risk; leaves open whether genotyping aids prediction or management.
To evaluate the association between angiotensin I-converting enzyme insertion/deletion (ACE I/D) gene polymorphism and retinal vein occlusion (RVO). A total of 80 patients with retinal vein occlusion who was admitted to the Eye Department of Kartal Training and Research Hospital between 2008 and 2011, and 80 subjects were enrolled in this retrospective case-control study. Patients who experienced RVO within one week to six months of study enrolment were included, and those with coronary artery diseases, prior myocardial infarction history and coagulation disturbances were excluded from the study. The diagnosis was made by ophthalmoscopic fundus examination and fluorescein angiography. The ACE gene I/D polymorphism was determined by polymerase chain reaction, and the ACE gene was classified into three types: I/I, I/D and D/D. In multivariate logistic regression analysis, ACE D/D genotype (p = 0.035), diabetes-mellitus (p = 0.019) and hypertension (p = 0.001) were found to be independent predictive factors for RVO. The results of the present study reveal that ACE D/D polymorphism is an independent predictive factor for RVO. However, one cannot definitely conclude that ACE gene polymorphism is a risk factor for retinal vein occlusion.
No takes yet. Share an insight, caveat, or question.
Karagöz et al. (2014) conducted a case-control in Retinal vein occlusion (n=160). ACE D/D genotype vs. Controls (without RVO) was evaluated on Retinal vein occlusion (OR 3.83, 95% CI 1.10-13.37, p=0.035). The ACE D/D genotype was found to be an independent predictive factor for retinal vein occlusion, significantly increasing the odds of the condition (OR 3.83, p=0.035).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: